Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, High-grade”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT00840047
What this trial is testing

Methionine PET/CT Studies In Patients With Cancer

Who this might be right for
Brain Tumors and/or Solid Tumors IncludingBrain Stem GliomaHigh Grade CNS Tumors+11 more
St. Jude Children's Research Hospital 503
Not applicableUnknownNCT03181373
What this trial is testing

IRM Cognition in Patients With Head Trauma

Who this might be right for
Brain-damaged Patients
University Hospital, Clermont-Ferrand 20
Not applicableLooking for participantsNCT06560372
What this trial is testing

Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital

Who this might be right for
SAH (Subarachnoid Hemorrhage)Cerebral VasospasmModerate Traumatic Brain Injury+1 more
University Hospital Center of Martinique 154
Testing effectiveness (Phase 2)Study completedNCT00003402
What this trial is testing

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
University of Maryland, Baltimore 35
Testing effectiveness (Phase 2)Study completedNCT00003039
What this trial is testing

Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Ended earlyNCT00003501
What this trial is testing

Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkins Lymphoma
Burzynski Research Institute 2
Testing effectiveness (Phase 2)Study completedNCT03484702
What this trial is testing

Trial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Celgene 113
Testing effectiveness (Phase 2)UnknownNCT02813330
What this trial is testing

Subcutaneous Sterile Water Injection for Relief of Low Back Pain

Who this might be right for
Low Back Pain
Woman's Health University Hospital, Egypt 336
Not applicableEnded earlyNCT02872298
What this trial is testing

Evaluating the Safety and Feasibility of TLD for the Treatment of Severe Asthma

Who this might be right for
Asthma
Nuvaira, Inc. 2
Not applicableStudy completedNCT03797404
What this trial is testing

Airway Remodeling During Mepolizumab Treatment

Who this might be right for
Asthma
Assistance Publique - Hôpitaux de Paris 37
Early research (Phase 1)Study completedNCT01897012
What this trial is testing

Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas

Who this might be right for
MYC PositiveRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Burkitt Lymphoma+14 more
National Cancer Institute (NCI) 26
Large-scale testing (Phase 3)Study completedNCT00015665
What this trial is testing

Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections

Who this might be right for
Mycoses
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableStudy completedNCT00049465
What this trial is testing

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Not applicableLooking for participantsNCT05496998
What this trial is testing

Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial

Who this might be right for
Mitral Regurgitation
Medtronic Cardiovascular 400
Large-scale testing (Phase 3)Study completedNCT01542034
What this trial is testing

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Who this might be right for
Moderate or Severe Submental Fullness
Kythera Biopharmaceuticals 506
Testing effectiveness (Phase 2)UnknownNCT04796857
What this trial is testing

Tislelizumab in Combination With Lenalidomide in Refractory and Relapsed Elderly Patients With Non-GCB DLBCL

Who this might be right for
Non-GCB/ABC Diffuse Large B-Cell LymphomaHigh-grade B-cell LymphomaFollicular Lymphoma Grade IIIb+3 more
Huiqiang Huang 30
Testing effectiveness (Phase 2)Study completedNCT00006125
What this trial is testing

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT03774082
What this trial is testing

Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant

Who this might be right for
Graft vs Host Disease
Novartis Pharmaceuticals 46
Testing effectiveness (Phase 2)Looking for participantsNCT05023018
What this trial is testing

NEO100 and High-Grade Meningioma

Who this might be right for
Residual, Progressive or Recurrent Grade II or III Meningioma
Neonc Technologies, Inc. 30
Early research (Phase 1)Study completedNCT00392691
What this trial is testing

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
Lymphoma
Swiss Cancer Institute 20
Next Page